Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers
Terminated
- Conditions
- Healthy
- Registration Number
- NCT00496171
- Lead Sponsor
- Photocure
- Brief Summary
The purpose of the study is to determine the most effective formulation of HAL for release of hexaminolevulinate to the cervical epithelium at different doses.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
- Healthy, pre-menopausal female volunteers
Exclusion Criteria
- Acute or chronic disease which could influence the study results
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Riks-Radium University Hospital
🇳🇴Oslo, Norway